Real-time enrollment status for this masld/mash (metabolic dysfunction-associated steatotic liver disease / metabolic dysfunction-associated steatohepatitis) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:15 PM UTC
| NCT Number | NCT07321925 |
| Recruiting Status | Recruiting |
| Condition | MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) |
| Phase | Clinical Trial |
| Target Enrollment | 49 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Endra Lifesciences |
| Last Updated on CT.gov | January 7, 2026 (Jan 7, 2026) |
As of July 13, 2026: Clinical trial NCT07321925 is currently recruiting participants. This clinical trial study for masld/mash (metabolic dysfunction-associated steatotic liver disease / metabolic dysfunction-associated steatohepatitis) is actively seeking new participants at 1 location across the United States. The study is sponsored by Endra Lifesciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07321925 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07321925 was last updated Jan 7, 2026 (January 7, 2026). HelloStudys verifies this status automatically.